Td Private Client Wealth LLC Dexcom Inc Transaction History

Td Private Client Wealth LLC

  • $3.48 Trillion
  • Q3 2024

A detailed history of Td Private Client Wealth LLC transactions in Dexcom Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 266 shares of DXCM stock, worth $21,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares
266
Previous 540 50.74%
Holding current value
$21,343
Previous $61.2 Million 70.87%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024
SELL
$64.0 - $116.06 $17,536 - $31,800
-274 Reduced 50.74%
266 $17.8 Million
Q2 2024

Aug 14, 2024
BUY
$110.31 - $140.45 $59,567 - $75,843
540 New
540 $61.2 Million
Q1 2024

Aug 16, 2024
BUY
$114.22 - $140.1 $1,827 - $2,241
16 Added 2.87%
573 $79.5 Million
Q4 2023

Aug 16, 2024
SELL
$75.49 - $124.16 $1,056 - $1,738
-14 Reduced 2.45%
557 $69.1 Million
Q3 2023

Aug 16, 2024
SELL
$86.06 - $137.93 $7,831 - $12,551
-91 Reduced 13.75%
571 $53.3 Million
Q2 2023

Aug 16, 2024
BUY
$112.47 - $130.98 $6,860 - $7,989
61 Added 10.15%
662 $85.1 Million
Q1 2023

Aug 16, 2024
SELL
$104.0 - $122.92 $1,248 - $1,475
-12 Reduced 1.96%
601 $69.8 Million
Q4 2022

Aug 16, 2024
BUY
$84.98 - $122.67 $14,871 - $21,467
175 Added 39.95%
613 $69.4 Million
Q3 2022

Aug 16, 2024
BUY
$76.35 - $94.18 $5,878 - $7,251
77 Added 21.33%
438 $35.3 Million
Q2 2022

Aug 16, 2024
BUY
$67.99 - $132.89 $17,949 - $35,082
264 Added 272.16%
361 $26.9 Million
Q1 2022

Aug 16, 2024
SELL
$94.08 - $130.2 $3,480 - $4,817
-37 Reduced 27.61%
97 $49.6 Million
Q4 2021

Aug 16, 2024
BUY
$129.87 - $162.82 $3,636 - $4,558
28 Added 26.42%
134 $72 Million
Q3 2021

Aug 16, 2024
SELL
$106.71 - $143.18 $46,312 - $62,140
-434 Reduced 80.37%
106 $58 Million
Q2 2021

Aug 16, 2024
BUY
$80.99 - $107.93 $3,644 - $4,856
45 Added 128.57%
80 $34.2 Million
Q1 2021

Aug 16, 2024
BUY
$84.79 - $104.74 $1,187 - $1,466
14 Added 66.67%
35 $12.6 Million
Q4 2020

Aug 16, 2024
SELL
$78.0 - $104.5 $4,056 - $5,434
-52 Reduced 71.23%
21 $7.76 Million
Q3 2020

Aug 16, 2024
SELL
$95.51 - $112.95 $1,241 - $1,468
-13 Reduced 15.12%
73 $30.1 Million
Q2 2020

Aug 16, 2024
BUY
$62.68 - $105.34 $1,943 - $3,265
31 Added 56.36%
86 $34.9 Million
Q1 2020

Aug 16, 2024
SELL
$47.79 - $75.63 $382 - $605
-8 Reduced 12.7%
55 $14.8 Million
Q4 2019

Aug 16, 2024
SELL
$36.62 - $57.29 $17,467 - $27,327
-477 Reduced 88.33%
63 $13.8 Million

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email